Cumberland Pharmaceuticals Ownership | Who Owns Cumberland Pharmaceuticals?


OverviewForecastRevenueFinancialsChartTranscripts

Cumberland Pharmaceuticals Ownership Summary


Cumberland Pharmaceuticals is owned by 22.78% institutional investors, 41.62% insiders, and 35.60% retail investors. Millennium management is the largest institutional shareholder, holding 5.42% of CPIX shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 2.01% of its assets in Cumberland Pharmaceuticals shares.

CPIX Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockCumberland Pharmaceuticals22.78%41.62%35.60%
SectorHealthcare Stocks 42.50%10.81%46.69%
IndustrySpecialty & Generic Drug Manufacturers Stocks26.16%11.89%61.94%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Millennium management809.90K5.42%$3.43M
Ikarian capital555.93K3.72%$1.73M
Renaissance515.47K3.45%$1.61M
Vanguard group411.79K2.75%$1.28M
Dimensional fund advisors lp280.87K1.88%$876.31K
J. goldman & co lp208.14K1.39%$649.41K
Bridgeway capital management188.35K1.26%$587.67K
Boothbay fund management168.13K1.12%$524.57K
Blackrock110.56K0.78%$169.16K
Geode capital management101.62K0.68%$317.10K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Ikarian capital555.93K0.18%$1.73M
Heron bay capital management31.66K0.02%$98.79K
J. goldman & co lp208.14K0.02%$649.41K
Bridgeway capital management188.35K0.01%$587.67K
Boothbay fund management168.13K0.01%$524.57K
Renaissance515.47K0.00%$1.61M
Millennium management809.90K0.00%$3.43M
Xtx topco10.59K0.00%$33.04K
Two sigma investments, lp37.59K0.00%$117.28K
Dimensional fund advisors lp280.87K0.00%$876.31K

Top Buyers

HolderShares% AssetsChange
Millennium management809.90K0.00%809.90K
Dimensional fund advisors lp280.87K0.00%27.98K
Renaissance515.47K0.00%20.50K
Two sigma investments, lp37.59K0.00%5.33K
Geode capital management101.62K-1.38K

Top Sellers

HolderShares% AssetsChange
Berkshire asset management llc/pa---153.81K
Adage capital partners gp---150.00K
Eam investors---71.78K
Walleye capital---70.42K
Ikarian capital555.93K0.18%-40.00K

New Positions

HolderShares% AssetsChangeValue
Millennium management809.90K0.00%809.90K$3.43M
Jones financial companies lllp600.00-600.00$1.85K
Farther finance advisors345.00-345.00$1.08K
Citigroup4.00-4.00$12.00

Sold Out

HolderChange
Jpmorgan chase-19.00
Advisor group-100.00
Wells fargo & company/mn-250.00
Innealta capital-948.00
Centiva capital, lp-1.60K

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 202532-3,406,301-7.49%223.76%9-40.00%1220.00%
Jun 30, 202532-17.95%3,682,268-13.97%243.00%15-21.05%1011.11%
Mar 31, 20253-85.71%1,549,897-15.86%106.04%3-25.00%--100.00%
Dec 31, 202421-8.70%1,842,038-9.87%136.20%4-55.56%10150.00%
Sep 30, 202423-4.17%2,043,812-1.62%146.70%950.00%4-20.00%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard US Total Market Shares ETF280.82K2.01%-
Vanguard Total Stock Mkt Idx Inv274.81K1.84%-6.01K
Bridgeway Ultra-Small Company137.27K0.92%4.20K
Vanguard Institutional Extnd Mkt Idx Tr86.94K0.58%-39.62K
IMC US Ultra Micro Cap79.25K0.53%-
DFA US Targeted Value I65.60K0.44%2.30K
Bridgeway Ultra-Small Company Market49.89K0.33%-
DFA US Micro Cap I47.77K0.32%-
Fidelity Extended Market Index44.18K0.30%1.02K
Pleiades Small Cap Equity A39.62K0.28%39.62K

Recent Insider Transactions


DateNameRoleActivityValue
Aug 27, 2025Young Caroline-Buy$20.64
Aug 26, 2025Young Caroline-Buy$20.34
Aug 29, 2025Young Caroline-Buy$20.70
Aug 28, 2025Young Caroline-Buy$20.82
Aug 25, 2025Young Caroline-Buy$19.92

Insider Transactions Trends


DateBuySell
2026 Q1--
2025 Q1--
2024 Q3--
2024 Q2--
2024 Q1--

CPIX Ownership FAQ


Who Owns Cumberland Pharmaceuticals?

Cumberland Pharmaceuticals shareholders are primarily institutional investors at 22.78%, followed by 41.62% insiders and 35.60% retail investors. The average institutional ownership in Cumberland Pharmaceuticals's industry, Specialty & Generic Drug Manufacturers Stocks, is 26.16%, which Cumberland Pharmaceuticals falls below.

Who owns the most shares of Cumberland Pharmaceuticals?

Cumberland Pharmaceuticals’s largest shareholders are Millennium management (809.9K shares, 5.42%), Ikarian capital (555.93K shares, 3.72%), and Renaissance (515.46K shares, 3.45%). Together, they hold 12.59% of Cumberland Pharmaceuticals’s total shares outstanding.

Does Blackrock own Cumberland Pharmaceuticals?

Yes, BlackRock owns 0.78% of Cumberland Pharmaceuticals, totaling 110.56K shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 169.16K$. In the last quarter, BlackRock decreased its holdings by 0 shares, a 0% change.

Who is Cumberland Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Ikarian capital is Cumberland Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 0.18% of its assets in 555.93K Cumberland Pharmaceuticals shares, valued at 1.73M$.

Who is the top mutual fund holder of Cumberland Pharmaceuticals shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of Cumberland Pharmaceuticals shares, with 2.01% of its total shares outstanding invested in 280.82K Cumberland Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools